This is a community-generated profile. If you would like to claim it, please .
Gemmus Pharma Funding
$0
22 rounds
Gemmus Pharma is active in the following markets / industries: biotechnology. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on May 13, 2014.
Investors of Gemmus Pharma
Michael Cain
cashed out entrepreneur, Managing member Wilmington Investor Network, Emgergent Growth Fund, Atlantis, Chairman Angel Resource Institute
The Angels Forum
Wilmington Investor Network
Rounds
B
A
Rounds
B
A
BlueTree Allied Angels
Rounds
B
A
Life Science Angels
Rounds
B
A
Founder and the Managing Member of both The Angels' Forum and The Halo Funds